title: Modulation of associated ovarian carcinoma antigens by 5 cytokines used as single agents or in combination.
abstract: Optimization of intraperitoneal radioimmunotherapy of ovarian cancer depends on increasing the antigenic expression of tumor cells. For this purpose, we studied the effect of 5 cytokines (IFN-alpha, IFN-beta, IFN-gamma, TNF-alpha and TGF-beta), used as single agents or in combination, on 4 ovarian cancer cell lines which present different antigenic profiles with the monoclonal antibodies (MAbs) tested (OC125, OVTL-3, MOv 18 and MOv 19). Analyses were performed by flow cytometry and the Scatchard technique in order to study antigenic modulation. The effect on proliferation was determined by cell counting. Expression of O3 antigen, recognized by the OVTL3 MAb, was increased up to 2.5 times after IFNs and TNF-alpha (used as single agent) on the 2 lines presenting low basal expression (SHIN-3 and IGROVI). The expression of CA125 antigen and the antigens recognized by MOv 18 and MOv 19 MAbs was not increased by any of the cytokines tested. The combination IFN-gamma+TNF-alpha was synergistic on cytotoxicity and enhanced O3 expression, providing 10 times as many sites per cell on the SHIN-3 line. For 3 other associations (IFN-alpha+IFN-gamma, IFN-beta+IFN-gamma and IFN-alpha+TNF-alpha), there was an additive effect on O3 expression and on cell cytotoxicity.
authors.affiliation: INSERM U211, Institut de Biologie, Nantes, France.
authors.forename: B M
authors.initials: BM
authors.lastname: Imbert-Marcille
authors.forename: P
authors.initials: P
authors.lastname: Thédrez
authors.forename: C
authors.initials: C
authors.lastname: Saï-Maurel
authors.forename: C
authors.initials: C
authors.lastname: François
authors.forename: J L
authors.initials: JL
authors.lastname: Auget
authors.forename: J
authors.initials: J
authors.lastname: Benard
authors.forename: Y
authors.initials: Y
authors.lastname: Jacques
authors.forename: S
authors.initials: S
authors.lastname: Imai
authors.forename: J F
authors.initials: JF
authors.lastname: Chatal
mesh_terms: D000951:Antigens, Neoplasm / Q000378:metabolism*; D016207:Cytokines / Q000494:pharmacology*; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000494:pharmacology; D016899:Interferon-beta / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology; D008233:Lymphotoxin-alpha / Q000494:pharmacology; D010051:Ovarian Neoplasms / Q000276:immunology*; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D000951:Antigens, Neoplasm; D016207:Cytokines; D016898:Interferon-alpha; D008233:Lymphotoxin-alpha; D014409:Tumor Necrosis Factor-alpha; D016899:Interferon-beta; D007371:Interferon-gamma